Last --
Change Today 0.00 / 0.00%
Volume 0.0
4502 On Other Exchanges
Symbol
Exchange
4502 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Toyoji Yoshida

Managing Director, Director and President of Takeda Pharmaceuticals International Inc, Takeda Pharmaceutical Company Limited
AgeTotal Calculated CompensationThis person is connected to 16 board members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background*

Mr. Toyoji Yoshida has been the Managing Director at Takeda Pharmaceutical Company Limited since 2009 and served as its Chief Administrative Officer until April 2012. Mr. Yoshida has been the President of Takeda Pharmaceuticals International Inc. since June 24, 2011 and serves as its Chief Administrative Officer and Managing Director. He served as General Manager of Corporate Communications Department of Takeda Pharmaceutical Co. Ltd. (formerly, Takeda Chemical Industries ...

Read Full Background

Corporate Headquarters*

1-1, Doshomachi 4-chome
Osaka, -- 540-8645

Japan

Phone: 81 6 6204 2111
Fax: 81 6 6204 2880

Board Members Memberships*

Former Corporate Auditor
2003-Present
Managing Director, Director and President of Takeda Pharmaceuticals International Inc

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4502:JP ¥4,486.00 JPY -50.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paul M. Bisaro Chairman, Chief Executive Officer and President
Actavis plc
$2.6M
Vincent A. Forlenza BDChairman, Chief Executive Officer and President
Becton, Dickinson and Company
$930.0K
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Karl-Ludwig Kley Chairman of Executive Board
Merck KGaA
€5.4M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.